Capitalize on Limitless Potential
Next Science came to us with a discovery: they had developed a chemical compound that was inexpensive, easy to make, completely non-toxic, and more effective than any other antibacterial (prescription, over-the-counter, industrial-strength, or otherwise) on the market today. It’s also the only product in existent that is proven effective against biofilms—bacterial communities that are up to 1000x more resistant to existing antibiotics than planktonic (individual) bacteria.
The applications for Next Science Technology are virtually limitless; from household cleaning to hospital sanitization, acne gel and mouthwash to chronic wound care and surgical dressing. However, these industries are dominated by industry giants with powerful R&D divisions, and regulatory agencies did not formally acknowledge the existence of biofilms, and had no process in place for approving biofilm-fighting claims. Working closely with the client and investors, CO OP built a brand designed to navigate the regulatory process and strategically break into monopolized markets to capitalize on the potential of Next Science.